Differential induction of human liver UDP-glucuronosyltransferase activities by phenobarbital-type inducers
- PMID: 2825716
- DOI: 10.1016/0006-2952(87)90572-7
Differential induction of human liver UDP-glucuronosyltransferase activities by phenobarbital-type inducers
Erratum in
- Biochem Pharmacol 1988 Mar 1;37(5):987
Abstract
(1) UDP-glucuronosyltransferase (UDP-GT) activities and their inducibility were investigated in human liver microsomes from a "liver bank". (2) UDP-GT activities were differentially induced in liver microsomes from patients treated with the phenobarbital-type inducers phenytoin or pentobarbital. UDP-GT activity towards bilirubin was induced 3-fold. Enzyme activities towards paracetamol, benzo(a)pyrene-3,6-quinol, 4-methylumbelliferone and 1-naphthol were moderately induced and to similar extents (2-fold). In contrast, morphine and 4-hydroxybiphenyl glucuronidation were not significantly affected. Cytochrome P-450 dependent 7-ethoxycoumarin O-deethylase was increased 5-fold. (3) A human hepatoma cell line (Hep G2) was studied to obtain information on the inducibility of human UDP-GT activities by 3-methylcholanthrene-type inducers. UDP-GT activities towards benzo(a)pyrene-3,6-quinol and 1-naphthol were moderately but significantly induced by 3-methylcholanthrene-treatment of the cells (2-fold), whereas 7-ethoxyresorufin O-deethylase and 7-ethoxycoumarin O-deethylase were increased over 100- and 10-fold, respectively. (4) The results suggest the existence of differentially inducible UDP-GT isoenzymes in human liver. The findings may be useful as a guide to characterize human liver UDP-GT isoenzymes.
Similar articles
-
Differential induction of rat liver microsomal UDP-glucuronosyltransferase activites by various inducing agents.Biochem Pharmacol. 1982 Mar 15;31(6):907-13. doi: 10.1016/0006-2952(82)90319-7. Biochem Pharmacol. 1982. PMID: 6805477
-
Studies of UDP-glucuronyltransferase activities in human liver microsomes.Drug Metab Dispos. 1984 Jan-Feb;12(1):93-7. Drug Metab Dispos. 1984. PMID: 6141920
-
Functional heterogeneity of UDP-glucuronosyltransferase activities in C57BL/6 and DBA/2 mice.Biochem Pharmacol. 1982 Apr 1;31(7):1273-7. doi: 10.1016/0006-2952(82)90015-6. Biochem Pharmacol. 1982. PMID: 6807317
-
Peroxisome proliferators as inducers and substrates of UDP-glucuronosyltransferases.Biol Cell. 1993;77(1):13-6. doi: 10.1016/s0248-4900(05)80169-8. Biol Cell. 1993. PMID: 8518741 Review.
-
Characterization and regulation of rat liver UDP glucuronosyltransferases.Clin Exp Pharmacol Physiol. 1989 Jun;16(6):501-4. doi: 10.1111/j.1440-1681.1989.tb01595.x. Clin Exp Pharmacol Physiol. 1989. PMID: 2504523 Review.
Cited by
-
Discrimination between Crigler-Najjar type I and II by expression of mutant bilirubin uridine diphosphate-glucuronosyltransferase.J Clin Invest. 1994 Dec;94(6):2385-91. doi: 10.1172/JCI117604. J Clin Invest. 1994. PMID: 7989595 Free PMC article.
-
Primary hepatocytes outperform Hep G2 cells as the source of biotransformation functions in a bioartificial liver.Ann Surg. 1994 Jul;220(1):59-67. Ann Surg. 1994. PMID: 8024360 Free PMC article.
-
Human hepatocytes as a key in vitro model to improve preclinical drug development.Eur J Drug Metab Pharmacokinet. 1990 Apr-Jun;15(2):165-71. doi: 10.1007/BF03190200. Eur J Drug Metab Pharmacokinet. 1990. PMID: 2200686 Review.
-
Expression of a high-affinity form of UDP-glucuronosyltransferase in human foetal liver cells in culture on exposure to mercuric chloride.Biochem J. 1991 Aug 15;278 ( Pt 1)(Pt 1):99-103. doi: 10.1042/bj2780099. Biochem J. 1991. PMID: 1909117 Free PMC article.
-
Newer antiepileptic drugs. Towards an improved risk-benefit ratio.Drug Saf. 1994 Jul;11(1):37-67. doi: 10.2165/00002018-199411010-00005. Drug Saf. 1994. PMID: 7917080 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous